Lifestyle Modification for High Blood Pressure and Obesity
(FIM-BCS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist Black women with both high blood pressure (hypertension) and obesity by enhancing their eating habits and better managing blood pressure. It features a 12-week program with cooking classes, grocery deliveries, and nutrition lessons. The trial incorporates RN-CHeFRx, a lifestyle modification program. It targets Black women with high blood pressure and a body mass index (BMI, a measure of body fat) of 30 or more. Participants should be able to cook at home and not have certain health conditions, such as cancer or liver disease. As an unphased trial, this study provides a unique opportunity for personalized lifestyle changes to improve health.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the RN-CHeFRx intervention is safe for participants?
Research has shown that the RN-CHeFRx program, which includes cooking classes, grocery delivery, and nutrition education, aims to improve diet and lifestyle. Although specific safety data for RN-CHeFRx is unavailable, similar programs are generally safe. They involve everyday activities like cooking and food delivery, which are not known to cause harm.
In similar studies, participants did not experience serious problems from lifestyle changes like eating healthier. This program does not include drugs or medical procedures, which typically have more safety concerns. Prospective participants can expect activities that are part of daily life, designed to help manage blood pressure and weight through better eating habits.12345Why are researchers excited about this trial?
Researchers are excited about the RN-CHeFRx treatment because it takes a "Food is Medicine" approach to tackle high blood pressure and obesity, which is quite different from traditional medication or lifestyle advice. Instead of focusing solely on pills or restrictive diets, RN-CHeFRx involves interactive cooking classes, providing grocery deliveries, and offering nutrition education. This hands-on, educational method empowers participants to make healthier choices and maintain these lifestyle changes long-term, which is a fresh take on managing these conditions.
What evidence suggests that the RN-CHeFRx intervention could be effective for hypertension and obesity?
Research has shown that nurse-led care can help manage high blood pressure in the short term. One study found that this care lowered the systolic blood pressure compared to regular care. Additionally, losing even a small amount of weight can help maintain lower blood pressure over time for those who are overweight. Obesity is closely linked to a higher risk of high blood pressure and related health issues. Overall, these findings suggest that the RN-CHeFRx program, which includes cooking classes, grocery delivery, and nutrition education, could effectively improve blood pressure and eating habits in Black women with high blood pressure and obesity.36789
Are You a Good Fit for This Trial?
This trial is for African-American breast cancer survivors who are dealing with obesity and high blood pressure. It aims to help them improve their eating habits and manage blood pressure through a 12-week program involving grocery delivery, cooking classes, and nutrition education.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo the RN-CHeFRx intervention, which includes grocery delivery, cooking classes, and nutrition education
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at baseline, 12 weeks, and 6 months
What Are the Treatments Tested in This Trial?
Interventions
- RN-CHeFRx
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor